UA Announces Research and Licensing Agreement With QRxPharma
The University of Alabama announced today a collaborative research and licensing agreement with QRxPharma, a clinical stage specialty pharmaceutical company (ASX: QRX), whose preclinical and clinical pipeline includes technologies in the fields of pain management and central nervous system disorders.